Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for orphan drugs
SPCs and orphan drugs-- is the double layer getting messy or is it just a matter of timing? A new ruling of the District Court in the Hague to shed some light? SPCs and orphan drugs-- is the double layer getting messy or is it just a matter of timing? A new ruling of the District Court in the Hague to shed some light? Reviewed by Frantzeska Papadopoulou on Monday, October 19, 2020 Rating: 5
Never Too Late: if you missed the IPKat last week Never Too Late: if you missed the IPKat last week Reviewed by Sophie Corke on Tuesday, April 07, 2020 Rating: 5
[Guest post] Covid-19 Treatments: The Issue of Orphan Drug Status and Patents [Guest post] Covid-19 Treatments: The Issue of Orphan Drug Status and Patents Reviewed by Frantzeska Papadopoulou on Friday, April 03, 2020 Rating: 5
Never Too Late: if you missed the IPKat last week! Never Too Late: if you missed the IPKat last week! Reviewed by Dr Rose Hughes on Wednesday, February 06, 2019 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.